7 Matching Annotations
  1. Jun 2021
  2. www.theguardian.com www.theguardian.com
    Oxygen shortages are killing thousands. Why aren't we doing more about this? | Charlotte Summers
    1
    1. jackiekrauss 09 Jun 2021

      Summers, C. (2021, June 8). Oxygen shortages are killing thousands. Why aren’t we doing more about this? | Charlotte Summers. The Guardian. http://www.theguardian.com/commentisfree/2021/jun/08/oxygen-shortages-killing-vaccines-drugs

      is:news lang:en oxygen vaccine drug therapy ventilator COVID-19 oxygen therapy hospital access inequality world supply
    Visit annotations in context

    Tags

    Annotators

    URL

    theguardian.com/commentisfree/2021/jun/08/oxygen-shortages-killing-vaccines-drugs
  3. Sep 2020
  4. search-credoreference-com.ccsf.idm.oclc.org search-credoreference-com.ccsf.idm.oclc.org
    Substance Abuse, Families, and Social Workers in the United States | The Wiley Blackwell Encyclopedia of Family Studies - Credo Reference
    1
    1. Rlozada0104 06 Sep 2020
      Specifically, social workers assist families by making referrals for alcohol and drug assessments, inpatient and outpatient treatment programs, family therapy, and support groups such as Alcoholics Anonymous

      What is the success rate of these programs? They DO NOT work... People with addiction problems need one on one help so they can understand their situation and what's going on i in their heads, and how they are impacting their children....

      The groups give them a swamp/ place to dwell. With Lillian, it was a place for her to feel sorry for herself and for others to "comfort" her. When she came home, we were the bad guys for not understanding.

      • programs are not a one size fit all. If they work at all.
      drug programs sucess rate therapy psychological problems victim mentality
    Visit annotations in context

    Tags

    Annotators

    URL

    search-credoreference-com.ccsf.idm.oclc.org/content/entry/wileyfamily/substance_abuse_families_and_social_workers_in_the_united_states/0
  5. Aug 2020
  6. www.siliconrepublic.com www.siliconrepublic.com
    RCSI team to start trial for promising Covid-19 therapy for severe infections
    1
    1. ErikStuchly 28 Aug 2020

      Gorey, C. (2020, June 29). RCSI team to start trial for promising Covid-19 therapy for severe infections. Silicon Republic. https://www.siliconrepublic.com/innovation/rcsi-trial-covid-19-therapy-alpha-1-antitrypsin

      is:news lang:en COVID-19 drug therapy clinical trial RCSI Ireland treatment randomized controlled trial crisis management global health epidemiology anti-inflammatory
    Visit annotations in context

    Tags

    Annotators

    URL

    siliconrepublic.com/innovation/rcsi-trial-covid-19-therapy-alpha-1-antitrypsin
  7. www.biorxiv.org www.biorxiv.org
    An Antioxidant Enzyme Therapeutic for COVID-19
    1
    1. ErikStuchly 28 Aug 2020

      Qin, M., Cao, Z., Wen, J., Yu, Q., Liu, C., Wang, F., Yang, F., Li, Y., Fishbein, G., Yan, S., Xu, B., Hou, Y., Ning, Z., Nie, K., Jiang, N., Liu, Z., Wu, J., Yu, Y., Li, H., … Lu, Y. (2020). An Antioxidant Enzyme Therapeutic for COVID-19. BioRxiv, 2020.07.15.205211. https://doi.org/10.1101/2020.07.15.205211

      is:preprint lang:en COVID-19 antioxidant activity enzyme catalase drug therapy intervention inflammation infection transmission immune response low cost
    Visit annotations in context

    Tags

    Annotators

    URL

    biorxiv.org/cgi/content/10.1101/2020.07.15.205211
  8. biorxiv.org biorxiv.org
    http://biorxiv.org/cgi/content/short/2020.08.05.238394
    1
    1. ErikStuchly 20 Aug 2020

      Luban, J., Sattler, R., Mühlberger, E., Graci, J. D., Cao, L., Weetall, M., Trotta, C., Colacino, J. M., Bavari, S., Strambio-De-Castillia, C., Suder, E. L., Wang, Y., Soloveva, V., Cintron-Lue, K., Naryshkin, N. A., Pykett, M., Welch, E. M., O’Keefe, K., Kong, R., … Peltz, S. (2020). The DHODH Inhibitor PTC299 Arrests SARS-CoV-2 Replication and Suppresses Induction of Inflammatory Cytokines. BioRxiv, 2020.08.05.238394. https://doi.org/10.1101/2020.08.05.238394

      is:preprint lang:en COVID-19 inflammatory cytokine suppression inflammation intervention inhibition blocked replication safety pharmacokinetics drug therapy selectivity
    Visit annotations in context

    Tags

    Annotators

    URL

    biorxiv.org/cgi/content/short/2020.08.05.238394
  9. May 2020
  10. www.thelancet.com www.thelancet.com
    Testing COVID-19 therapies to prevent progression of mild disease
    1
    1. Marlene_Wulf 07 May 2020

      Lipsitch, M., Perlman, S., & Waldor, M. K. (2020). Testing COVID-19 therapies to prevent progression of mild disease. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(20)30372-8

      is:article lang:en COVID-19 testing therapy progression disease influenza antiviral drug placebo symptom treatment oseltamivir
    Visit annotations in context

    Tags

    Annotators

    URL

    thelancet.com/journals/laninf/article/PIIS1473-3099(20)30372-8/fulltext
  11. Apr 2020
  12. www.thelancet.com www.thelancet.com
    Flooded by the torrent: the COVID-19 drug pipeline
    1
    1. edampf 24 Apr 2020

      Mullard, A. (2020). Flooded by the torrent: The COVID-19 drug pipeline. The Lancet, 395(10232), 1245–1246. https://doi.org/10.1016/S0140-6736(20)30894-1

      is:article COVID-19 lang:en drug treatment trial research pharmaceutical therapy healthcare clinical WHO China Gilead data collection antiviral antibody immune system infection
    Visit annotations in context

    Tags

    Annotators

    URL

    thelancet.com/journals/lancet/article/PIIS0140-6736(20)30894-1/fulltext